CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This research study involves Niraparib as a possible treatment for triple negative breast cancer....
Phase 1
Boston, Massachusetts, United States and 1 other location
This research study is studying immunotherapy as a possible treatment for metastatic Triple Negative Breast Cancer...
Phase 1
Boston, Massachusetts, United States and 2 other locations
This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative b ...
Phase 2
Boston, Massachusetts, United States and 9 other locations
of durvalumab in combination with novel oncology therapies with or without paclitaxel and durvalumab + paclitaxel for first-line metastatic triple...
Phase 1, Phase 2
Boston, Massachusetts, United States and 31 other locations
inhibitor as a possible adjuvant treatment for Stage II or III Triple Negative Breast Cancer. This research study...
Phase 1
Boston, Massachusetts, United States and 4 other locations
The purpose of this study is to determine if a combination of two drugs ipatasertib and atezolizumab works as a treatment for residual cancer...
Phase 2
Boston, Massachusetts, United States and 8 other locations
This research is being done to evaluate the safety and effectiveness of Onvansertib in combination with Paclitaxel in triple-negative...
Phase 1, Phase 2
Boston, Massachusetts, United States and 2 other locations
This research study is studying to evaluate sacituzumab govitecan for individuals with localized triple negative breast ca...
Phase 2
Boston, Massachusetts, United States and 4 other locations
This research study is studying a drug called Carboplatin with or without another study drug, Nivolumab as a possible treatment for triple-n ...
Phase 2
Boston, Massachusetts, United States and 9 other locations
oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through selective inhibition of phosphoin ...
Phase 2
Boston, Massachusetts, United States and 23 other locations
Clinical trials
Research sites
Resources
Legal